Designing of spherical chitosan nano-shells with micellar cores for solvation and safeguarded delivery of strongly lipophilic drugs

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 529, Issue , 2017, Pages 815-823

  Cihan, Esra ^a   Polat, Mehmet ^a   Polat, Hurriyet ^a  

^a IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Chitosan; Lipophilic drug(s); Micelle(s); Nano shell(s); Nanoparticle(s)

Indexed keywords

ACETONE; AUTOMOBILE MANUFACTURE; BIOCOMPATIBILITY; CHITOSAN; DYNAMIC LIGHT SCATTERING; GELATION; HYDROPHOBICITY; MICELLES; PH SENSORS; SHELLS (STRUCTURES);

CHITOSAN PARTICLES; LIPOPHILIC DRUGS; MICELLAR STRUCTURES; NANO METER RANGE; PLURONIC COPOLYMERS; POSITIVE CHARGES; SYNTHESIS PROCEDURE; SYNTHESIZED PARTICLES;

CHITIN;

ACETIC ACID; ACETONITRILE; CHITOSAN NANOPARTICLE; COPOLYMER; DODECYL SULFATE SODIUM; NANOSHELL; POLOXAMER; PROBUCOL; TRIPOLYPHOSPHATE;

ARTICLE; CHEMICAL STRUCTURE; CROSS LINKING; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; HYDROPHOBICITY; LIPOPHILICITY; MICELLE; PARTICLE SIZE; PH; POLYMERIZATION; PRIORITY JOURNAL; SOLVATION; SURFACE CHARGE; SURFACE TENSION; ZETA POTENTIAL;

EID: 85022004893     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2017.06.074     Document Type: Article

References (55)

1. Fahmy, T.M., Fong, P.M., Goyal, A., Saltzman, W.M., Targeted for drug delivery. Mater. Today 8 (2005), 18–26.
2. Gerweck, L.E., Tumor pH: implications for treatment and novel drug design. Semin. Radiat. Oncol. 8 (1998), 176–182.
3. Calvo, P., Remunan-Lopez, C., Vila-Jato, J.L., Alonso, J., The potential of chitosan for pulmonary drug delivery. J. Appl. Polym. Sci. 63 (1997), 125–132.
4. Zou, X., Zhao, X., Ye, L., Wang, Q., Li, H., Preparation and drug release behavior of pH-responsive bovine serum albumin-loaded chitosan microspheres. J. Ind. Eng. Chem. 21 (2015), 1389–1397.
5. Chen, F., Zhu, Y., Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range. Microporous Mesoporous Mater. 150 (2012), 83–89.
6. Jee, J.P., Na, J.H., Lee, S., Kim, S.H., Choi, K., Yeo, Y., Kwon, I.C., Cancer targeting strategies in nanomedicine: design and application of chitosan nanoparticles. Curr. Opin. Solid State Mater. Sci. 16 (2012), 333–342.
7. Yuan, Q., Subramanian, R., Hein, S., Misra, R.D.K., Stimuli-responsive magnetic nanoparticle drug carrier: magnetite encapsulated with chitosan grafted-copolymer. Acta Biomater. 4 (2008), 1024–1037.
8. Yuan, Q., Shah, J., Hein, S., Misra, R.D.K., Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater. 6 (2010), 1140–1148.
9. Ohya, Y., Shiratani, M., Kobayashi, H., Ouchi, T., Release behaviour of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem., A31, 1994, 629642.
10. Songjiang, Z., Lixiang, W., Amyloid-Beta associated with chitosan nano-carrier has favorable immunogenicity and permeates the BBB. AAPS PharmSciTech 10 (2009), 900–905.
11. Tokumitsu, H., Ichikawa, H., Fukumori, Y., Block, L.H., Chem Preparation of gadopentetic acidloaded chitosan microparticles for gadolinium neutron-capture therapy of cancer by a novel emulsion-droplet coalescence technique. Pharm. Bull. 47 (1999), 838–842.
12. Anto, S.M., Kannan, C., Kumar, K.S., Kumar, S.V., Suganeshwari, M., Formulation of 5-fluorouracil loaded chitosan nanoparticles by emulsion droplet coalescence method for cancer therapy. Int. J. Pharm. Biol. Arch. 2 (2011), 926–931.
13. El-Shabouri, M.H., Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J Pharm. 249 (2002), 101–108.
14. Mitra, S., Gaur, U., Ghosh, P.C., Maitra, A.N., Tumor targeted delivery of encapsulated dextrandoxorubicin conjugate using chitosan nanoparticles as carriers. J. Controlled Release 74 (2001), 317–323.
15. Banerjee, T., Mitra, S., Singh, A.K., Sharma, R.K., Maitra, A., Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int. J. Pharm. 243 (2002), 93–105.
16. Tang, Z.-X., Qian, J.-Q., Xi, L.-E., Biochem, Appl., Preparation of chitosan nanoparticles as carrier for immobilized enzyme. Biotechnol 136 (2007), 77–96.
17. Manchanda, R., Nimesh, R., Controlled size chitosan nanoparticles as an efficient, biocompatible oligonucleotides delivery system. J. Appl. Polym. Sci. 118 (2010), 2071–2077.
18. De Campos, A., Sanchez, A., Alonso, M.J., Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int. J. Pharm. 224 (2001), 159–168.
19. Ma, Z., Yeoh, H.H., Lim, L.-Y., Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J. Pharm. Sci. 91 (2002), 1396–1404.
20. Wang, J., Byrne, J.D., Napier, M.E., DeSimone, J.M., More effective nanomedicines through particle design. Small 7 (2011), 1919–1931.
21. Fan, W., Yan, W., Xu, Z., Ni, H., Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloid Surf. B: Biointerfaces 90 (2012), 21–27.
22. Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., Remy, J.-S., Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm. Res. 15 (1998), 1332–1333.
23. Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., Yang, C., Synthesis and characterization of chitosanpoly(acrylic acid) nanoparticles. Biomaterials, 23, 2002, 31933201.
24. Du, J., Sun, R., Zhang, S., Govender, T., Zhang, L.F., Xiong, C.D., Peng, Y.X., Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. Macromol. Rapid Commun. 25 (2004), 954–958.
25. Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., Development and characterization of new insulin containing polysaccharide nanoparticles. Colloid Surf. B: Biointerfaces 53 (2006), 193–202.
26. Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., Neufeld, R., Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8 (2007), 3054–3060.
27. Lin, Y.-H., Mi, F.-L., Chen, C.-T., Chang, W.-C., Peng, S.-F., Liang, H.-F., Sung, H.-W., Preparation and characterisation of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8 (2007), 146–152.
28. Bayat, A., Larijani, B., Ahmadian, S., Junginger, H.E., Rafiee-Tehrani, M., Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomed. Nanotechnol. Biol. Med. 4 (2008), 115–120.
29. Lin, Y.-H., Sonaje, K., Lin, K.M., Juang, J.-H., Mi, F.-L., Yang, H.-W., Sung, H.-W., Multi-ioncrosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J. Controlled Release 132 (2008), 141–149.
30. Teijeiro-Osorio, D., Remuñan-López, C., Alonso, M.J., Biomacromolecules 10 (2009), 243–249.
31. Avadi, M.R., Sadeghi, A.M.M., Mohammadpour, N., Abedin, S., Atyabi, F., Dinarvand, R.M., Rafiee-Tehrani, Preparation and characterization of insulin nanoparticles using chitosan and arabic gum with ionic gelation method. Nanomed. Nanotechnol. Biol. Med. 6 (2010), 58–63.
32. Grenha, A., Gomes, M.E., Rodrigues, M., Santo, V.E., Mano, J.F., Neves, N.M., Reis, R.L., Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J. Biomed Mater. Res. 92A (2010), 1265–1272.
33. Kaihara, S., Suzuki, Y., Fujimoto, K., In situ synthesis of polysaccharide nanoparticles via polyion complex of carboxymethyl cellulose and chitosan. Colloid Surf. B: Biointerfaces 85 (2011), 343–348.
34. Yeh, M.K., Cheng, K.M., Hu, C.S., Huang, Y.C., Young, J.J., Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization. Acta Biomater. 7 (2011), 3012–3804.
35. Sajeesh, S., Sharma, C.P., Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm. 325 (2006), 147–154.
36. Sajeesh, S., Sharma, C.P., Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery. J. Biomed. Mater. Res. 76 B (2006), 298–305.
37. Mao, H.-Q., Roy, K., Troung-Le, V.L., Janes, K.A., Lin, K.Y., Wang, Y., August, J.T., Leong, K.W., Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Controlled Release 70 (2001), 399–421.
38. Borges, O., Borchard, G., Verhoef, J.C., Sousa, A., Junginger, H.E., Preparation of coated nanoparticles for a new mucosal vaccine delivery systems. Int. J. Pharm 229 (2005), 155–166.
39. Agnihotri, S.A., Aminabhavi, T.M., Chitosan nanoparticles for prolonged delivery of timolol maleate. Drug Dev. Ind. Pharm. 33 (2007), 1254–1262.
40. Atyabi, F., Talaie, F., Dinarvand, R., Thiolated chitosan nanoparticles as an oral delivery system for amikacin: in vitro and ex vivo evaluations. J. Nanosci. Nanotechnol. 9 (2009), 4593–4603.
41. Kabanov, A.V., Batrakova, E.V., Alakhov, V.Y., Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Controlled Release 82 (2002), 189–212.
42. Foster, B., Cosgrove, T., Hammouda, B., Pluronic triblock copolymer systems and their interactions with ibuprofen. Langmuir 25 (2009), 6760–6766.
43. Alexandridis, P., Hatton, A., Poly (ethylene oxide)-poly (propylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. Colloids Surf. A 96 (1995), 1–46.
44. Bhattacharjee, J., Verma, G., Aswal, V.K., Patravalec, V., Hassan, P.A., Microstructure drug binding and cytotoxicity of Pluronic P123–aerosol OT mixed micelles. RSC Adv. 3 (2013), 23080–23089.
45. Yang, C.H., Lin, Y.S., Huang, K.S., Huang, Y.C., Wang, E.C., Jhong, J.Y., Kuo, C.Y., Microfluidic emulsification and sorting assisted preparation of monodisperse chitosan microparticles. Lab Chip 9 (2009), 145–150.
46. Cihan, E., Design of Micelle Embedded Chıtosan Nano Composites for Targeted Delivery of Hydrophobic Drugs MSc Thesis. 2016, Izmir Institute of Technology.
47. Oyane, A., Kim, H.M., Furuya, T., Kokubo, T., Miyazaki, T., Nakamura, T., Preparation and assessment of revised simulated body fluids. J. Biomed. Mater. Res. A 65 (2003), 188–195.
48. Dutra, L.M.U., M.E.N.P, Rilbeiro, Cavalcante, I.M., de Brito, D.H.A., Semiao, L.M., de Silva, R.F., P.B.A.Fechine, S.G.Yeates, Ricardo, N.M.P.S., Binary mixtures micellar systems of F127 and P123 for griseofulvin solubilisation. Polimeros 25 (2015), 433–439.
49. Petrov, P., Yuan, J., Yoncheva, K., Müller, A.H.E., Tsvetanov, C.B., Wormlike morphology formation and stabilization of pluronic P123 micelles by solubilization of pentaerythritol tetraacrylate. J. Phys. Chem. B 112 (2008), 8879–8883.
50. Corazzari, I., Nisticò, R., Turci, F., Faga, M.G., Franzoso, F., Tabasso, S., Magnacca, G., Advanced physico-chemical characterization of chitosan by means of TGA coupled on-line with FTIR and GCMS: Thermal degradation and water adsorption capacity. Polym. Degrad. Stab. 112 (2015), 1–9.
51. Ajun, W., Yan, S., Li, G., Huili, L., Preparation of aspirin and probucol in combination loaded chitosan nanoparticles and in vitro release study. Carbohydr. Polym. 75 (2009), 566–574.
52. Sarma, R., Dambarudhar, M., Luminescence and bio-imaging response of thio-glycolic acid (TGA) and sodium dodecyl sulfate (SDS)-coated fluorescent cadmium selenide quantum dots. J. Lumin. 161 (2015), 395–402.
53. Jindal, N., Mehta, S.K., Nevirapine loaded Poloxamer 407/Pluronic P123 mixed micelles: optimization of formulation and in vitro evaluation. Colloids Surf. B: Biointerfaces 129 (2015), 100–106.
54. Walke, S., Srivastava, G., Nikalje, M., Doshi, J., Kumar, R., Ravetkar, S., Doshi, P., Fabrication of chitosan microspheres using vanillin/TPP dual crosslinkers for protein antigens encapsulation. Carbohydr. Polym. 128 (2015), 188–198.
55. Griffiths, J.R., Are cancer cells acidic?. Br. J. Cancer 64 (1991), 425–427.